Patent · US Active

In-vitro method for testing bioequivalence of iron-sucrose formulation

US8058076B2 · kind B2 · utility

1Cited by

5References

14Claims

0Family size

Assignee

ASTRON RESEARCH LIMITED · IN

Inventors

Samir Shah · Ahmedabad, IN
Keyur R. Patel · Saginaw, US
Sanjay Dash · Ahmedabad, IN
Kuldeep Dilip Karnik · Ahmedabad, IN
Ashish SEHGAL · Ahmedabad, IN
Bhavesh Patel · Bensalem, US
Jayanta Kumar MANDAL · Ahmedabad, IN

Key dates

Filing date	Mar 29, 2010
Grant date	Nov 15, 2011
Priority date	—
Expiry date	Apr 18, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/15
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to an in vitro method for measuring the T75 of reduction kinetics of iron from Fe+3 to Fe+2 in an iron-sucrose complex and hence assessing the bioequivalency of iron-sucrose composition. According to the disclosed method, T75 of reduction kinetics of iron in an iron-sucrose complex in between 25 to 50 minutes indicates bioequivalent iron-sucrose composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.